Delivery Order SPE2DB22D2206-SPE2DB25FHR25

Award Date 6/27/25
Potential Completion Date 7/21/25
Potential Value $43K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tagrisso 80 mg tablets. The contract has a ceiling value of $21,325.14 and is a firm fixed-price delivery order with a performance period through May 14, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Tagrisso 80 mg tablet, with a ceiling value of $10,662.57 and a period of performance through May 9, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside and is open to full and open competition. Amerisourcebergen...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of Tagrisso 80 mg tablets, a specialty pharmaceutical product. The award has a ceiling value of $21,077.60 and a completion date of April 12, 2024. No set-aside designation was used. AmerisourceBergen Drug Corp also holds an...
This is a $42,607.28 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tagrisso 80 mg tablets, a cancer medication, with a period of performance through July 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a $10,538.79 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the medical product "TAGRISSO 80 MG TABLET 30S" and has an ultimate completion date of July 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,641.07, is for the delivery of the prescription medication Tagrisso 40 mg tablets. The contract is a Firm Fixed Price Delivery Order, with a performance period through May 8, 2025. This award is not associated with a set-aside program and represents open competition....
This is a $21,325.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a prescription medication, with a period of performance through July 3, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of pharmaceutical products. The $10,247.06 firm fixed-price contract is for the delivery of Tagrisso 80 mg tablets. The contract has an ultimate completion date of July 26, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $31,987.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Tagrisso 80 mg tablet, with an ultimate completion date of May 13, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Tagrisso 80 mg tablet in 30-count packages, with a total ceiling value of $10,662.57. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 13, 2025. AmerisourceBergen Drug Corp holds a significant...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FHR25
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tagrisso 80 mg tablets, with a ceiling value of $42,650.28 and a period of performance through July 21, 2025. The contract is not set-aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/26/25, 9:57 AM